Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move ...

The sensor patch market was valued at $1.6 billion in 2022, and is estimated to reach $56.4 billion by 2032, growing at a CAGR of 43.2% from 2023 to 2032. Proactive surge in manufacturing output, ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

Plus: Crebrid secures $500 million credit facility in partnership with Barings and John Paul Mitchell Systems relocates its ...

Nine analysts recently shared their mixed yet mostly positive outlook on Abbott Laboratories, highlighting raised price targets and bullish sentiment. Analysts raised the average 12-month price target ...

Find the latest information on Abbott Laboratories Common Stock (ABT) insider activity and insider shares traded to make sound investments with Nasdaq.com.